‘Into the Woods’ – Managing co-morbidities in airways disease最新文献

筛选
英文 中文
P210 The impact of introducing anti-IL-5/5R biologic therapies on weight and BMI in prednisolone-dependent patients with severe asthma P210引入抗il -5/ 5r生物疗法对强的松龙依赖严重哮喘患者体重和BMI的影响
‘Into the Woods’ – Managing co-morbidities in airways disease Pub Date : 2022-11-01 DOI: 10.1136/thorax-2022-btsabstracts.343
VM Taylor, T. Patrick, A. Hearn, J. Kavanagh, L. Thomson, JL Lam, L. Green, M. Fernandes, C. Roxas, G. d'Ancona, J. Dhariwal, D. Jackson, A. Nanzer
{"title":"P210 The impact of introducing anti-IL-5/5R biologic therapies on weight and BMI in prednisolone-dependent patients with severe asthma","authors":"VM Taylor, T. Patrick, A. Hearn, J. Kavanagh, L. Thomson, JL Lam, L. Green, M. Fernandes, C. Roxas, G. d'Ancona, J. Dhariwal, D. Jackson, A. Nanzer","doi":"10.1136/thorax-2022-btsabstracts.343","DOIUrl":"https://doi.org/10.1136/thorax-2022-btsabstracts.343","url":null,"abstract":"","PeriodicalId":280688,"journal":{"name":"‘Into the Woods’ – Managing co-morbidities in airways disease","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130010398","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
P216 Effect of structured cardiac assessment on survival without readmission after hospitalisation with exacerbation of chronic obstructive pulmonary disease (COPD) P216结构化心脏评估对慢性阻塞性肺疾病(COPD)加重住院后无再入院生存的影响
‘Into the Woods’ – Managing co-morbidities in airways disease Pub Date : 2022-11-01 DOI: 10.1136/thorax-2022-btsabstracts.348
J. Kibbler, D. Ripley, S. Bourke, J. Steer
{"title":"P216 Effect of structured cardiac assessment on survival without readmission after hospitalisation with exacerbation of chronic obstructive pulmonary disease (COPD)","authors":"J. Kibbler, D. Ripley, S. Bourke, J. Steer","doi":"10.1136/thorax-2022-btsabstracts.348","DOIUrl":"https://doi.org/10.1136/thorax-2022-btsabstracts.348","url":null,"abstract":"","PeriodicalId":280688,"journal":{"name":"‘Into the Woods’ – Managing co-morbidities in airways disease","volume":"18 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126202143","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
P213 Real-world effectiveness of benralizumab in patients with eosinophilic granulomatosis with polyangiitis (EGPA) benralizumab治疗嗜酸性肉芽肿合并多血管炎(EGPA)患者的实际疗效
‘Into the Woods’ – Managing co-morbidities in airways disease Pub Date : 2022-11-01 DOI: 10.1136/thorax-2022-btsabstracts.345
V. Alam, S. Agarwal, C. Hopkins, D. D’cruz, M. Fernando, TF Ismail, J. Dhariwal, A. Nanzer, D. Jackson
{"title":"P213 Real-world effectiveness of benralizumab in patients with eosinophilic granulomatosis with polyangiitis (EGPA)","authors":"V. Alam, S. Agarwal, C. Hopkins, D. D’cruz, M. Fernando, TF Ismail, J. Dhariwal, A. Nanzer, D. Jackson","doi":"10.1136/thorax-2022-btsabstracts.345","DOIUrl":"https://doi.org/10.1136/thorax-2022-btsabstracts.345","url":null,"abstract":"","PeriodicalId":280688,"journal":{"name":"‘Into the Woods’ – Managing co-morbidities in airways disease","volume":"26 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121250378","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
P215 A systematic literature review of factors related to mortality in patients with COPD P215对COPD患者死亡率相关因素的系统文献综述
‘Into the Woods’ – Managing co-morbidities in airways disease Pub Date : 2022-11-01 DOI: 10.1136/thorax-2022-btsabstracts.347
D. Gibson, M. Siddiqui, J. Hurst, D. Stolz, M. Verma, S. Sharma, U. Holmgren
{"title":"P215 A systematic literature review of factors related to mortality in patients with COPD","authors":"D. Gibson, M. Siddiqui, J. Hurst, D. Stolz, M. Verma, S. Sharma, U. Holmgren","doi":"10.1136/thorax-2022-btsabstracts.347","DOIUrl":"https://doi.org/10.1136/thorax-2022-btsabstracts.347","url":null,"abstract":"","PeriodicalId":280688,"journal":{"name":"‘Into the Woods’ – Managing co-morbidities in airways disease","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130832735","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
P209 A total diet replacement weight management programme for difficult-to-treat asthma associated with obesity: a randomised controlled trial 全饮食替代体重管理方案治疗难治性哮喘伴肥胖:一项随机对照试验
‘Into the Woods’ – Managing co-morbidities in airways disease Pub Date : 2022-11-01 DOI: 10.1136/thorax-2022-btsabstracts.342
V. Sharma, H. Ricketts, L. McCombie, N. Brosnahan, L. Crawford, L. Slaughter, A. Goodfellow, F. Steffensen, R. Chaudhuri, M. Lean, D. Cowan
{"title":"P209 A total diet replacement weight management programme for difficult-to-treat asthma associated with obesity: a randomised controlled trial","authors":"V. Sharma, H. Ricketts, L. McCombie, N. Brosnahan, L. Crawford, L. Slaughter, A. Goodfellow, F. Steffensen, R. Chaudhuri, M. Lean, D. Cowan","doi":"10.1136/thorax-2022-btsabstracts.342","DOIUrl":"https://doi.org/10.1136/thorax-2022-btsabstracts.342","url":null,"abstract":"","PeriodicalId":280688,"journal":{"name":"‘Into the Woods’ – Managing co-morbidities in airways disease","volume":"9 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126930334","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
P207 The influence of obesity on the clinical outcome of benralizumab treatment in severe eosinophilic asthma a subgroup analysis from the BPAP study 肥胖对benralizumab治疗严重嗜酸性哮喘临床结果的影响——来自BPAP研究的亚组分析
‘Into the Woods’ – Managing co-morbidities in airways disease Pub Date : 2022-11-01 DOI: 10.1136/thorax-2022-btsabstracts.341
A. Nanzer, H. Burhan, A. Menzies-Gow, H. Rupani, P. Pfeffer, I. Clifton, S. Faruqi, J. Dhariwal, T. Morris, J. Lipworth, M. Watt, D. Jackson
{"title":"P207 The influence of obesity on the clinical outcome of benralizumab treatment in severe eosinophilic asthma a subgroup analysis from the BPAP study","authors":"A. Nanzer, H. Burhan, A. Menzies-Gow, H. Rupani, P. Pfeffer, I. Clifton, S. Faruqi, J. Dhariwal, T. Morris, J. Lipworth, M. Watt, D. Jackson","doi":"10.1136/thorax-2022-btsabstracts.341","DOIUrl":"https://doi.org/10.1136/thorax-2022-btsabstracts.341","url":null,"abstract":"","PeriodicalId":280688,"journal":{"name":"‘Into the Woods’ – Managing co-morbidities in airways disease","volume":"20 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116842170","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
P211 Asthma in pregnancy: how are we doing? A service evaluation across general asthma and severe asthma clinics in a tertiary hospital 妊娠期哮喘:我们做得怎么样?对某三级医院普通哮喘和严重哮喘门诊的服务评价
‘Into the Woods’ – Managing co-morbidities in airways disease Pub Date : 2022-11-01 DOI: 10.1136/thorax-2022-btsabstracts.344
A. Thomas, H. Durrington, L. Holmes
{"title":"P211 Asthma in pregnancy: how are we doing? A service evaluation across general asthma and severe asthma clinics in a tertiary hospital","authors":"A. Thomas, H. Durrington, L. Holmes","doi":"10.1136/thorax-2022-btsabstracts.344","DOIUrl":"https://doi.org/10.1136/thorax-2022-btsabstracts.344","url":null,"abstract":"","PeriodicalId":280688,"journal":{"name":"‘Into the Woods’ – Managing co-morbidities in airways disease","volume":"7 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114551869","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
P217 Experience with tumour necrosis factor-alpha inhibitors for the treatment of cardiac sarcoidosis in a U.K. medical centre P217在英国医疗中心用肿瘤坏死因子- α抑制剂治疗心脏结节病的经验
‘Into the Woods’ – Managing co-morbidities in airways disease Pub Date : 2022-11-01 DOI: 10.1136/thorax-2022-btsabstracts.349
R. Ahmed, J. Okafor, R. Shi, A. Azzu, K. Wechalekar, J. Baksi, D. Pennell, P. Collins, A. Wells, R. Khattar, R. Sharma, V. Kouranos
{"title":"P217 Experience with tumour necrosis factor-alpha inhibitors for the treatment of cardiac sarcoidosis in a U.K. medical centre","authors":"R. Ahmed, J. Okafor, R. Shi, A. Azzu, K. Wechalekar, J. Baksi, D. Pennell, P. Collins, A. Wells, R. Khattar, R. Sharma, V. Kouranos","doi":"10.1136/thorax-2022-btsabstracts.349","DOIUrl":"https://doi.org/10.1136/thorax-2022-btsabstracts.349","url":null,"abstract":"P217 Table 1Case series outcomes table Case no. IFX dose& regime Follow-up duration (months) Change in prednisolone dose Change in FDG-PET uptake Change in LV systolic function Change in arrythmia burden Adverse events Composite Endpoint Dose pre-IFX(mg) Dose post-IFX(mg) Pre-IFX Post-IFX LVEF pre-IFX (%) LVEF post-IFX(%) Pre-IFX Post-IFX Infections Heart failure VT/VF (requiring device) All-cause mortality Aborted SCD (device) Cardiac Transplant Case 1 IFX 3 mg/kg every 8 weeks (break after 10th dose due to covid pandemic;restarted 3 months later) 29 20 15 Active CS(SUVmax 11.1) Improvement(SUVmax3.5) 58 59 N/A N/A 0 0 0 0 0 0 Case 2 IFX 3 mg/kg every 8 weeks. Stopped after 15.6 months due to resolution 15.6 10 10 Active CS(SUVmax 10.2) Improvement(SUVmax 2.65) 55 62 VA 0 1 (chest infection) 0 0 0 0 0 Case 2Relapse (7 months after stopping IFX) due to VT and FDG uptake IFX 3 mg/kg every 8 weeks 12 10 10 Active CS(SUVmax 3.3) Improvement(no uptake) N/A 50 VA 0 0 Mild LVSD 0 0 0 0 Case 3 IFX 3 mg/kg0 weeks and 4 weeks;missed 8 weeks’ appointment due to COVID-19 10 20 20 Active CS(SUVmax 11.3) N/A 55 N/A 0 N/A 1 (Covid-19) 0 0 0 0 0 Case 4 IFX 3 mg/kg at 0, 2 and 8 weeks afterwards 16 20 10 Active CS(SUVmax 13) Improved(SUVmax 3.4) 45 66 VA N/A 0 0 0 1 (PFO and shunt/complications) 0 0 Case 5 IFX 3 mg/kg 0, 2, 6 and every 8 weeks 8.5 30 15 Active CS(SUVmax 11.3) Improved(no uptake) 46 51 VA 0 0 0 0 0 0 0 Totals 6 IFX 3 mg/kg Mean=15.2 Mean=18.3 Mean=13.3 All had active CS 5 improved;1 data not available Mean=51.8 Mean=57.6 4 had VAs;1 data not available None had VA;3 had data not available 2 1 0 1 0 0 CS = cardiac sarcoidosis;FDG-PET =fluorodeoxyglucose positron emission tomography;IFX = Infliximab;LV = left ventricular;LVEF = left ventricular ejection fraction;LVSD = left ventricular systolic dysfunction;N/A = data not available;PFO= patent foramen ovale;","PeriodicalId":280688,"journal":{"name":"‘Into the Woods’ – Managing co-morbidities in airways disease","volume":"7 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128713687","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
P214 Oral corticosteroid-related healthcare resource utilisation in patients with COPD 慢性阻塞性肺病患者口服皮质类固醇相关医疗资源的利用
‘Into the Woods’ – Managing co-morbidities in airways disease Pub Date : 2022-11-01 DOI: 10.1136/thorax-2022-btsabstracts.346
G. Tse, C. Ariti, M. Bafadhel, A. Papi, V. Carter, J. Zhou, D. Skinner, X. Xu, H. Müllerová, B. Emmanuel, Daniel J. Price
{"title":"P214 Oral corticosteroid-related healthcare resource utilisation in patients with COPD","authors":"G. Tse, C. Ariti, M. Bafadhel, A. Papi, V. Carter, J. Zhou, D. Skinner, X. Xu, H. Müllerová, B. Emmanuel, Daniel J. Price","doi":"10.1136/thorax-2022-btsabstracts.346","DOIUrl":"https://doi.org/10.1136/thorax-2022-btsabstracts.346","url":null,"abstract":"","PeriodicalId":280688,"journal":{"name":"‘Into the Woods’ – Managing co-morbidities in airways disease","volume":"56 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121507251","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书